No Prescription |
 |
 | ||
|
LASILACTONE Aldactone |
|
| ||
No Prescription » Prescription Drugs 10 » LASILACTONE Aldactone Spironolactone is used to treat certain patients with hyperaldosteronism (the body produces too much aldosterone a naturally occurring hormone); low potassium levels; and in patients with edema (fluid retention) caused by various conditions including heart liver or kidney disease. Spironolactone is also used alone or with other medications to treat high blood pressure. Spironolactone is in a class of medications called aldosterone receptor antagonists. It causes the kidneys to eliminate unneeded water and sodium from the body into the urine but reduces the loss of potassium from the body.Furosemide a 'water pill ' is used to reduce the swelling and fluid retention caused by various medical problems including heart or liver disease. It is also used to treat high blood pressure. It causes the kidneys to get rid of unneeded water and salt from the body into the urine.Spironolactone/Furosemide comes as a tablet to take by mouth. It usually is taken once a day in the morning or sometimes twice a day . Take Lasilactone at around the same time(s) every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take spironolactone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Your doctor may start you on a low dose of Lasilactone and gradually increase your dose. Lasilactone controls high blood pressure and hyperaldosteronism but does not cure these conditions.. It may take about 2 weeks or longer before the full effect of spironolactone occurs. Continue to take spironolactone even if you feel well. Do not stop taking spironolactone without talking to your doctor.Lasilactone combination with other medicines to treat precocious puberty (a condition causing children to enter puberty too soon resulting in the development of sexual characteristics in girls usually younger than 8 years of age and in boys usually younger than 9 years of age) or myasthenia gravis (MG a disease in which the nerves do not function properly and patients may experience weakness; numbness; loss of muscle coordination; and problems with vision speech and bladder control). Lasilactone also may be used to treat certain female patients with abnormal facial hair. Talk to your doctor about the possible risks of using this medication for your condition. Buy LASILACTONE Aldactone and other Prescription Drugs 10 products online at Medstore. 948
About LASILACTONE Aldactone: Product Type: Prescription Drugs 10 LASILACTONE ( Aldactone Generic Spironolactone/Furosemide ) LASILACTONE (Aldactone Generic Spironolactone/Furosemide) Aldactone Generic Spironolactone/Furosemide 50 mg + 20 mg Tabs 100 (10 x 10) Aldactone Generic Spironolactone/Furosemide LASILACTONE
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
